• Sarepta Therapeutics EPS for the quarter ending September 30, 2024 was $0.34, a 173.91% decline year-over-year.
• Sarepta Therapeutics 2023 annual EPS was $-5.8, a 27.77% decline from 2022.
• Sarepta Therapeutics 2022 annual EPS was $-8.03, a 55.92% increase from 2021.
• Sarepta Therapeutics 2021 annual EPS was $-5.15, a 27.57% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.